News
intravitreal injections
Cancer drug may also be a possible treatment for age-related macular degeneration
Clinical trials are set to launch later this year to evaluate whether the cancer drug, PRL3-zumab, is effective in treating wet age-related macular degeneration (AMD) as well as diabetic retinopathy.
cataract surgery
Cataract surgery complications increase with past history of intravitreal injections
Study results were recently presented at the annual meeting of the American Academy of Ophthalmology that reveal an increased risk of post cataract surgery complications for patients with a histor...
anti-VEGF
New anti-VEGF therapy shows promise in Phase 1 Clinical trial
The new drug is manufactured by 4D Molecular Therapeutics and is a dual-transgene intravitreal gene therapy.
age-related macular degeneration
Port Delivery System therapy looking for FDA approval
The new device offers a continuous therapeutic dose of ranibizumab to the eye in place of regular eye injections.
anti-VEGF injections
Neovascular Macular Degeneration Patients Can Gain Visual Acuity After Cataract Surgery
Researchers compared the visual outcomes and rate of intraoperative complications in patients with nAMD and control eyes that did not have nAMD that underwent phacoemulsification cataract surgery o...